Literature DB >> 11497151

Cardiopulmonary effects of nitric oxide inhalation and methylene blue injection in hepatopulmonary syndrome.

V Jounieaux, O Leleu, I Mayeux.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11497151     DOI： 10.1007/s001340100967

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  5 in total

1.  Exhaled nitric oxide and oxygenation abnormalities in hepatic cirrhosis.

Authors:  G Rolla; L Brussino; P Colagrande; L Dutto; S Polizzi; E Scappaticci; S Bergerone; M Morello; A Marzano; G Martinasso; M Salizzoni; C Bucca
Journal:  Hepatology       Date:  1997-10       Impact factor: 17.425

2.  Endogenous pulmonary nitric oxide production measured from exhaled air is increased in patients with severe cirrhosis.

Authors:  P Sogni; P Garnier; A Gadano; R Moreau; J Dall'Ava-Santucci; A T Dinh-Xuan; D Lebrec
Journal:  J Hepatol       Date:  1995-10       Impact factor: 25.083

3.  Elevated exhaled nitric oxide in patients with hepatopulmonary syndrome.

Authors:  G Cremona; T W Higenbottam; V Mayoral; G Alexander; E Demoncheaux; C Borland; P Roe; G J Jones
Journal:  Eur Respir J       Date:  1995-11       Impact factor: 16.671

4.  Methylene blue in the hepatopulmonary syndrome.

Authors:  G Rolla; C Bucca; L Brussino
Journal:  N Engl J Med       Date:  1994-10-20       Impact factor: 91.245

5.  Exhaled nitric oxide and impaired oxygenation in cirrhotic patients before and after liver transplantation.

Authors:  G Rolla; L Brussino; P Colagrande; E Scappaticci; M Morello; S Bergerone; A Ottobrelli; E Cerutti; S Polizzi; C Bucca
Journal:  Ann Intern Med       Date:  1998-09-01       Impact factor: 25.391
  5 in total
  5 in total

Review 1.  Hepatopulmonary syndrome: What we know and what we would like to know.

Authors:  Israel Grilo-Bensusan; Juan Manuel Pascasio-Acevedo
Journal:  World J Gastroenterol       Date:  2016-07-07       Impact factor: 5.742

Review 2.  Hepatopulmonary Syndrome.

Authors:  Yong Lv; Daiming Fan
Journal:  Dig Dis Sci       Date:  2015-03-03       Impact factor: 3.199

Review 3.  Proposed management algorithm for severe hypoxemia after liver transplantation in the hepatopulmonary syndrome.

Authors:  D Nayyar; H S J Man; J Granton; L B Lilly; S Gupta
Journal:  Am J Transplant       Date:  2015-02-03       Impact factor: 8.086

Review 4.  Hepatopulmonary syndrome: An update.

Authors:  Kejal D Gandhi; Pahnwat Tonya Taweesedt; Munish Sharma; Salim Surani
Journal:  World J Hepatol       Date:  2021-11-27

Review 5.  Pharmacological treatment for hepatopulmonary syndrome.

Authors:  Ahad Eshraghian; Amir A'lam Kamyab; Seung Kew Yoon
Journal:  Biomed Res Int       Date:  2013-09-12       Impact factor: 3.411
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.